January 16, 2025

EHR Systems Boost Depression Screening in cSLE

Discover how automated EHR-driven systems significantly improved depression screening rates for youth with childhood-onset systemic lupus erythematosus in a pediatric rheumatology clinic.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Updated TMS Guidelines for Depression Treatment

Explore the latest transcranial magnetic stimulation guidelines for depression, including updated protocols, safety data, and tailored recommendations for clinicians.

Conexiant

January 10, 2025

Disparities in U.S. TBI Mortality: 2021 Analysis

Explore traumatic brain injury-related mortality trends.

Conexiant

January 08, 2025

Limited Use of Gender-Affirming Medications in Teens

New study reports rare use of puberty blockers and gender-affirming hormones among U.S. transgender adolescents from 2018 to 2022.

Conexiant

January 06, 2025

Prenatal Steroids Linked to Autism, ADHD

Prenatal glucocorticoid exposure is linked to a higher risk of mental disorders in offspring.

Conexiant

January 03, 2025

Online Recruitment Fraud: Challenges and Strategies

Explore strategies to identify and mitigate fraudulent responses in online health research, with exclusion rates reaching up to 94%.

Conexiant

January 02, 2025

Glutamatergic Drugs Reduce OCD Symptoms, Study Shows

A meta-analysis suggests that glutamatergic medications significantly reduce obsessive-compulsive disorder symptoms but calls for further research due to study limitations.

Conexiant

December 27, 2024

11 Medical Breakthroughs This Year

Explore medical breakthroughs from 2024, including advancements in Parkinson’s therapy, ulcerative colitis treatments, and gene therapy for hereditary deafness.

Conexiant